A Study to Evaluate Glucose and Insulin Response to Nutralin
NCT ID: NCT01275820
Last Updated: 2011-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2010-06-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin
NCT01275027
Glycemic Response to Oral Nutrition Supplements
NCT02612675
Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas
NCT00540488
Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes
NCT00753181
Glycemic Response to Two Enteral Formulas in Persons With Type 2 Diabetes Mellitus
NCT02898766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nutralin
All 10 subjects in the study will consume the investigational food product.
Nutralin
Food product to be taken 15 minutes prior to each of the three main meals of the day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutralin
Food product to be taken 15 minutes prior to each of the three main meals of the day.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-diabetic
Exclusion Criteria
* Women who are pregnant, breastfeeding or planning to become pregnant
* Current and active liver or kidney disease
* Any food allergies
* Celiac disease
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vintek, LLC
UNKNOWN
Avera McKennan Hospital & University Health Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Avera Research Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edward Zawada, MD
Role: PRINCIPAL_INVESTIGATOR
Avera McKennan Hospital & University Health Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Avera Research Institute
Sioux Falls, South Dakota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARI-1330-Nutralin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.